ArticleQuantitative imaging in medicine and surgery2024
DeepNeXt: a lightweight polyp segmentation algorithm based on multi-scale attention.
Article in Quantitative imaging in medicine and surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- EMCAH-Net: an effective multi-scale context aggregation hybrid network for medical image segmentation.Quantitative imaging in medicine and surgery · 2025Article
- Deep learning model for gastrointestinal polyp segmentation.PeerJ. Computer science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fast and accurate automatic segmentation of polyps in colonoscopy plays a crucial role in the early diagnosis and treatment of colon cancer. However, the current polyp segmentation algorithms based on deep neural networks suffer from the problems of larger models and lower segmentation accuracy. Meanwhile, achieving accurate segmentation of polyps is to improve the diagnostic efficiency of doctors, and this need motivates us to develop a set of lightweight models so that it can be easily embedded in clinical devices to meet the requirements of practical applications. This study aims to provide effective technical support for the rapid and precise segmentation of polyps in clinical applications. Methods: DeepNeXt, an innovative polyp segmentation model grounded in multi-scale attention mechanisms. DeepNeXt incorporates a multi-stage, lightweight convolutional encoder module, leveraging several lightweight convolutional layers for efficient and accurate feature extraction. Furthermore, it features a novel multi-stage feature fusion structure designed to circumvent the potential loss of feature information during the encoding phase. Additionally, the model employs a multi-scale attentional feature encoding module that harnesses multi-branch deep strip convolution techniques to extract multi-dimensional information from the feature maps post-encoding, thereby enhancing the neural network's capability to extract diverse feature information. Results: Experimental validation on the Kvasir Segmentation Dataset (Kvasir-SEG dataset) and Colorectal Cancer-Clinic Datasetbase (CVC-ClinicDB datasets) demonstrates that DeepNeXt outperforms mainstream networks such as U-net, U-net++, TransUnet, SwinUnet, and TGANet in terms of parameters and floating-point operations (FLOPs). DeepNeXt achieved a FLOPs metric of only 3.04 G and a parameters (Params) metric of just 1.51 M, while delivering exceptional performance in segmentation. On the Kvasir-SEG dataset, it reached a mean intersection over union (mIOU) of 83.91, and on the CVC-ClinicDB dataset, 87.37. Additionally, the Dice and Recall metrics also showed superior results, highlighting that DeepNeXt strikes an optimal balance between computational efficiency, model compactness, and segmentation accuracy. Conclusions: In conclusion, we have proposed the DeepNeXt network, a novel lightweight multi-scale attention segmentation network tailored for computationally limited medical devices, which provides strong support for accurate and efficient polyp segmentation in clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.